NIA Magellan, InformedDNA to Offer Genetic Benefits Optimization Solution
December 22 2014 - 04:54PM
Business Wire
Collaboration will couple NIA Magellan’s robust
infrastructure with InformedDNA’s clinical genetics expertise and
national provider network
Magellan Health, Inc. (NASDAQ: MGLN) today announced that NIA
Magellan, which offers a suite of specialty solutions to address
many complex areas of healthcare, will collaborate with InformedDNA
to offer an evidence-based genetic benefits optimization program.
InformedDNA’s national network of independent board-certified
genetics specialists provides expert clinical review services to
ensure appropriate use of genetic testing and improve patient care,
while at the same time delivering significant cost savings.
With rapid growth in the number of new genetic tests being
brought to market, and the high rate of inappropriate ordering,
this collaboration provides a critical solution by offering genetic
testing guidance by independent genetics specialists to patients
and physicians alike. This approach has been proven to deliver
high-quality, cost-effective and clinically actionable genetic
testing.
“Advances in genetic testing are at the forefront of
personalized healthcare, enabling individuals to make informed
choices about their healthcare,” said Tina M. Blasi, chief
executive officer of NIA Magellan. “With those advancements,
however, we must also ensure we are diligently monitoring the
clinical appropriateness of genetic testing, and most importantly,
that we are providing the genetic counseling and information
necessary for individuals to best understand the results and any
subsequent care that may be needed. Collaborating with InformedDNA
will provide our customers and their members with genetics
expertise, that when coupled with NIA Magellan’s existing
infrastructure and clinical leadership, will help to improve care
and avoid unnecessary and costly tests. I’m excited about offering
this cutting-edge capability.”
“As the premier genetic benefits management organization,
deploying InformedDNA’s genetics expertise within NIA Magellan's
established technology infrastructure allows InformedDNA to
continue our rapid growth with health plan customers of all sizes,”
stated InformedDNA chief executive officer David Nixon.
“Personalized medicine will continue to be one of the most powerful
trends in healthcare for years to come. Collaborating with NIA
Magellan positions us to expand delivery of our highly successful
patient-centric approach that improves care while optimizing
costs," Nixon concluded.
NIA Magellan’s suite of specialty solutions includes diagnostic
imaging management services, as well as programs that manage the
evaluation and therapy associated with cardiology services,
musculoskeletal management, radiation oncology, obstetrical
ultrasounds, and sleep management.
InformedDNA empowers personalized healthcare by providing
genetics expertise to health plans, decision support to providers
and expert genetic counseling services to patients.
About Magellan Health: Headquartered in Scottsdale,
Ariz., Magellan Health, Inc. is a healthcare management company
that focuses on fast-growing, complex and high-cost areas of
healthcare, with an emphasis on special population management.
Magellan delivers innovative solutions to improve quality outcomes
and optimize the cost of care for those we serve. Magellan’s
customers include health plans, managed care organizations,
insurance companies, employers, labor unions, various military and
government agencies, third party administrators, consultants and
brokers. For more information, visit MagellanHealth.com.
About InformedDNA: InformedDNA helps individuals and
healthcare providers accurately interpret family health history and
genetics, bringing the promise of personalized healthcare to life.
InformedDNA is the authority on the appropriate use of genetic
testing – leveraging the expertise of the largest network of
independent genetics specialists to help ensure health plans,
hospitals, employers, community clinicians and patients all have
access to the highest quality genetic services. InformedDNA's key
offerings include clinical genetic counseling, genetic testing
utilization management, and personalized hereditary risk assessment
and prevention solutions. For more information, visit
www.informeddna.com.
Magellan Health, Inc.Media Contact:Colleen Flanagan
Johnson, 860-507-1923cefjohnson@magellanhealth.comorInvestor
Contact:Renie Shapiro Silver,
877-645-6464rshapiro@magellanhealth.com
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Mar 2023 to Mar 2024